Augmenting Demand for Antibiotic-Associated Diarrhea Treatment to Bolster Global Market Revenue Growth

Antibiotic-Associated Diarrhea Treatment Market is Segmented On the basis of route of administration ( Oral , Injectable ), On the basis of distribution channel ( Hospital Pharmacy, Retail Pharmacies, Drug Stores, Online Pharmacy)

Antibiotics are generally recommended by doctors for bacterial infections. While fighting the infectious bacteria, antibiotics kill the good bacteria present in the intestine as well, which results in diarrhea. As antibiotics kill the good bacteria, it disrupts the balance of the intestine and increases the bad bacteria resistant to antibiotics. Therefore, it can be said that Antibiotic-associated diarrhea is a side effect of antibiotics. It has been observed that, majority of the time, diarrhea ceases post the course of the antibiotic; however, it may become serious and lead to hospitalization in many cases. Probiotics such as yogurts and fermented products are advised as they help in the functioning of the digestive system.

Antibiotics that commonly cause Antibiotic-associated diarrhea include cephalosporins such as cefixime, cefpodoxime, penicillins and clostridium. Also, attributing to the high dosage of a broad spectrum of antibiotics, hospitalized patients may also suffer from diarrhea. At times, Antibiotic-associated diarrhea occurs 2 to 8 weeks after the antibiotics have been discontinued. When a patient is observed to be suffering from diarrhea, the first line of treatment includes maintaining adequate amount of water and discontinuing the drug. The patient should be given electrolytes and fluid as a supportive treatment for the improvement of his health.

To remain ‘ahead’ of your competitors, request for a Brochure–https://www.factmr.com/connectus/sample?flag=B&rep_id=1288

Antibiotic-Associated Diarrhea treatment market: Drivers and Restraints

The prevalence of antibiotic-associated diarrhea treatment market has increased due to the availability of over the counter drugs which has attributed to increase the prevalence of Antibiotic-associated diarrhea Moreover the patients opt for self-prescribed drugs for the treatment of the disease rather than consulting a doctor which is driving the Antibiotic-associated diarrhea treatment market. Moreover the rise in the technology and development of online pharmacies is also making patients opt for self-treatments. The overall Antibiotic-associated diarrhea treatment market is pushed by the increasing demand for growing expenditure on healthcare and patient safety. However home remedies and treatment may decrease the growth of the market.

Antibiotic-Associated diarrhea treatment market: Segmentation

Tentatively, the global Antibiotic-Associated diarrhea treatment market can be segmented on the basis of route of administration and distribution channel.

On the basis of route of administration, the global antibiotic-associated diarrhea treatment market can be segmented into:
Oral
Injectable

On the basis of distribution channel, the global antibiotic-associated diarrhea treatment market can be segmented into:
Hospital Pharmacy
Retail Pharmacies
Drug Stores
Online Pharmacy

Get Customization on this Research Report for specific research solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=1288

Antibiotic-Associated Diarrhea Treatment Market: Market Participants
The global market for Antibiotic-associated diarrhea treatment is highly fragmented. Examples of some of the key players operating in the global antibiotic-associated diarrhea treatment market include

CutisPharma, Inc
Pfizer Inc
Manav Drugs Pvt Ltd
Aurobindo Pharma Limited
AdvaCare Pharma
Cadila Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Teva Pharmaceutical Industries Ltd.
among others

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Antibiotic-Associated diarrhea treatment market: Segmentation
Tentatively, the global Antibiotic-Associated diarrhea treatment market can be segmented on the basis of route of administration and distribution channel.

On the basis of route of administration, the global antibiotic-associated diarrhea treatment market can be segmented into:

Oral
Injectable
On the basis of distribution channel, the global antibiotic-associated diarrhea treatment market can be segmented into:

Hospital Pharmacy
Retail Pharmacies
Drug Stores
Online Pharmacy

More Related Reports by Fact.MR on Healthcare:

Veterinary Endodontics Market: https://www.factmr.com/report/veterinary-endodontics-market

Therapeutic Support Surface Market: - https://www.factmr.com/report/therapeutic-support-surface-market

Computer-Assisted Orthopedic Surgery Market: - https://www.factmr.com/report/computer-assisted-orthopedic-surgery-market

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.